Manufacture of bulk chemicals and bulk pharmaceutical ingredients for preclinical and clinical studies
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201700020C
- Awardee
-
Alchem Laboratories Corporation UEI LD2KY6H7KMQ5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,809,618
Award facts
- Opportunity
-
- N02CM7700798 Solicitation number
- Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies Award Notice · Posted Mar 3, 2017
- Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies Award Notice · Posted Feb 9, 2017
- Contract value 98% obligated
-
- $2,809,617.81 Current, with exercised options
- $2,858,496.81 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Santa Fe, FL 32615, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$1,573 | |
| Funding Only Action | -$73 | |
| Funding Only Action | $46,184 | |
| Supplemental Agreement for work within scope | -$806 | |
| Funding Only Action | $52,000 | |
| Funding Only Action | $200,000 | |
| Exercise an Option | $300,000 | |
| Funding Only Action | $311,255 | |
| Supplemental Agreement for work within scope | $270,000 | |
| Supplemental Agreement for work within scope | $162,304 | |
| Exercise an Option | $400,000 | |
| Funding Only Action | $274,121 | |
| Exercise an Option | $269,883 | |
| Funding Only Action | $133,196 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $268,126 | |
| Original award | $125,000 |
Show all 17
About this award
The National Cancer Institute awarded a $2.86 million definitive contract to Alchem Laboratories Corporation for manufacture of bulk chemicals and bulk pharmaceutical ingredients for preclinical and clinical studies on August 1, 2017, under a total small business set-aside.
The contract is cost-plus-fixed-fee and supports the FY26 UDO Initiative. Place of performance is Alachua, FL. The ultimate completion date is June 4, 2022.
Service Contract Inventory data reflects actual government invoicing across the contract's reported span. FY2021 generated $2.3 million in invoiced costs across 6.6 FTEs and 13,821 contractor hours, yielding a derived hourly rate of $168.18. FY2022 invoicing declined to $376 thousand across 1.5 FTEs and 3,157 contractor hours at a derived rate of $119.21 per hour. The prime self-performed all reported labor with no subcontractors.
Quick answers
Who was awarded contract HHSN261201700020C?
HHSN261201700020C was awarded to Alchem Laboratories Corporation by National Cancer Institute (National Institutes of Health) on August 1, 2017.
How much is contract HHSN261201700020C worth?
The government has obligated $2,809,618 on HHSN261201700020C. Its potential value, with all options, is $2,858,497.
Was contract HHSN261201700020C competed?
The extent of competition for HHSN261201700020C was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award